Accessibility Menu
Intelligent Bio Solutions logo

Intelligent Bio Solutions

(NASDAQ) INBS

Current Price$2.20
Market Cap$5.49M
Since IPO (2020)-100%
5 Year-100%
1 Year-88%
1 Month-14%

Intelligent Bio Solutions Financials at a Glance

Market Cap

$5.49M

Revenue (TTM)

$3.91M

Net Income (TTM)

-$11.61M

EPS (TTM)

-$12.32

P/E Ratio

-0.19

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$2.20

Volume

66,077

Open

$2.27

Previous Close

$2.20

Daily Range

$2.18 - $2.31

52-Week Range

$2.18 - $24.90

Estimated Earnings Date

Aug 14, 2026

INBS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intelligent Bio Solutions

Industry

Healthcare Equipment and Supplies

Employees

55

CEO

Harry Simeonidis

Website

ibs.inc

Headquarters

New York City, NY 10019, US

INBS Financials

Key Financial Metrics (TTM)

Gross Margin

32.08%

Operating Margin

-300.26%

Net Income Margin

-296.76%

Return on Equity

-174.16%

Return on Capital

-324.73%

Return on Assets

-78.13%

Earnings Yield

-5.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.49M

Shares Outstanding

2.39M

Volume

66.08K

Avg. Volume

121.25K

Financials (TTM)

Gross Profit

$1.26M

Operating Income

-$11.75M

EBITDA

-$10.40M

Operating Cash Flow

-$11.10M

Capital Expenditure

-$336.04K

Free Cash Flow

-$11.44M

Cash & ST Invst.

$6.86M

Total Debt

$1.85M

Intelligent Bio Solutions Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$1.06M

+45.5%

Gross Profit

$244.99K

+522.0%

Gross Margin

23.09%

N/A

Market Cap

$5.49M

N/A

Market Cap/Employee

$109.79K

N/A

Employees

50

N/A

Net Income

-$2.86M

-12.5%

EBITDA

-$2.58M

-15.3%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$6.86M

+144.5%

Total Debt

$1.85M

+261.6%

Accounts Receivable

$1.45M

+40.3%

Inventory

$597.47K

-12.6%

Long Term Debt

$1.46M

+39308.2%

Short Term Debt

$388.75K

-23.4%

Return on Assets

-78.13%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

-$4.47M

-61.3%

Operating Cash Flow

-$4.48M

-62.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSCSHeartSciences Inc.
$2.63-4.36%
POAIPredictive Oncology Inc.
$4.91+6.28%
PAVMPAVmed Inc.
$4.67-0.22%
ADILAdial Pharmaceuticals, Inc.
$2.48-2.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
WENWendy's
$7.86+0.26%
AALAmerican Airlines Group
$17.44+0.08%
NOKNokia
$13.81+0.01%
IBITiShares Bitcoin Trust
$33.87-0.04%

Questions About INBS

What is the current price of Intelligent Bio Solutions?

Intelligent Bio Solutions is trading at $2.20 per share.

What is the 52-week range for Intelligent Bio Solutions?

Over the past 52 weeks, Intelligent Bio Solutions has traded between $2.18 and $24.90.

How much debt does Intelligent Bio Solutions have?

As of the most recent reporting period, Intelligent Bio Solutions reported total debt of $1.85M.

How much cash does Intelligent Bio Solutions have on hand?

Intelligent Bio Solutions reported $6.86M in cash and cash equivalents in its most recent financial results.

What is Intelligent Bio Solutions’s dividend yield?

Intelligent Bio Solutions does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.